Clinical Parameters Predicting Pathologic Tumor Response After Preoperative Chemoradiotherapy for Rectal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 4, 2007, Pages 1167-1172

  Yoon, Sang Min ^a   Kim, Dae Yong ^a   Kim, Tae Hyun ^a   Jung, Kyung Hae ^a   Chang, Hee Jin ^a   Koom, Woong Sub ^a   Lim, Seok Byung ^a   Choi, Hyo Seong ^a   Jeong, Seung Yong ^a   Park, Jae Gahb ^a  

^a National Cancer Center   (South Korea)

Author keywords

Downstaging; Preoperative chemoradiotherapy; Rectal cancer; Tumor regression

Indexed keywords

BIOLOGICAL ORGANS; CATHODE RAY TUBES; CHEMOTHERAPY; HEMOGLOBIN; PATHOLOGY; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

PATHOLOGIC TUMOR RESPONSES; PREOPERATIVE CHEMORADIOTHERAPY; RECTAL CANCER; TUMOR REGRESSIONS;

ONCOLOGY;

CAPECITABINE; CARCINOEMBRYONIC ANTIBODY; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR REGRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOEMBRYONIC ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; REMISSION INDUCTION;

EID: 35448950560     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.047     Document Type: Article

References (34)

1. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
2. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
3. Chan A.K., Wong A., Jenken D., et al. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 665-677
4. Das P., Skibber J.M., Rodriguez-Bigas M.A., et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29 (2006) 219-224
5. Garcia-Aguilar J., Hernandez de Anda E., Sirivongs P., et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46 (2003) 298-304
6. Kaminsky-Forrett M.C., Conroy T., Luporsi E., et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42 (1998) 935-941
7. Theodoropoulos G., Wise W.E., Padmanabhan A., et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (2002) 895-903
8. Losi L., Luppi G., Gavioli M., et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy. Int J Colorectal Dis 21 (2006) 645-651
9. Valentini V., Coco C., Picciocchi A., et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53 (2002) 664-674
10. Bouzourene H., Bosman F.T., Seelentag W., et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94 (2002) 1121-1130
11. Rodel C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
12. Vecchio F.M., Valentini V., Minsky B.D., et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 752-760
13. Chang H.J., Jung K.H., Kim D.Y., et al. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol 36 (2005) 364-371
14. Giralt J., Eraso A., Armengol M., et al. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 1460-1465
15. Rau B., Sturm I., Lage H., et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 21 (2003) 3391-3401
16. Smith F.M., Reynolds J.V., Kay E.W., et al. COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 466-472
17. Zlobec I., Steele R., and Compton C.C. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy. Cancer 104 (2005) 2517-2521
18. Watanabe T., Komuro Y., Kiyomatsu T., et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66 (2006) 3370-3374
19. Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
20. Kim Y.H., Kim D.Y., Kim T.H., et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 761-768
21. Kim J.H., Beets G.L., Kim M.J., et al. High-resolution MR imaging for nodal staging in rectal cancer: Are there any criteria in addition to the size?. Eur J Radiol 52 (2004) 78-83
22. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer staging manual. 6th ed. (2002), Springer, Philadelphia
23. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 (1997) 19-23
24. Janjan N.A., Crane C., Feig B.W., et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24 (2001) 107-112
25. Glynne-Jones R., Mawdsley S., Pearce T., et al. Alternative clinical end points in rectal cancer-Are we getting closer?. Ann Oncol 17 (2006) 1239-1248
26. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 979-994
27. Park Y.A., Sohn S.K., Seong J., et al. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol 93 (2006) 145-150
28. Das P., Skibber J.M., Rodriguez-Bigas M.A., et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109 (2007) 1750-1755
29. Varlotto J., and Stevenson M.A. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 63 (2005) 25-36
30. van Halteren H.K., Houterman S., Verheij C.D., et al. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. Eur J Surg Oncol 30 (2004) 628-632
31. Nastro P., Beral D., Hartley J., et al. Local excision of rectal cancer: Review of literature. Dig Surg 22 (2005) 6-15
32. Willett C.G., Warland G., Coen J., et al. Rectal cancer: The influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 32 (1995) 57-61
33. Francis Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 17 (1999) 2396-2402
34. Beets-Tan R.G., and Beets G.L. Rectal cancer: Review with emphasis on MR imaging. Radiology 232 (2004) 335-346